US49714P1084 - Common Stock

Overall **KNSL** gets a fundamental rating of **6** out of 10. We evaluated **KNSL** against 141 industry peers in the **Insurance** industry. While **KNSL** belongs to the best of the industry regarding profitability, there are concerns on its financial health. **KNSL** is valued quite expensive, but it does show an excellent growth.

In the past year **KNSL** had a positive cash flow from operations.

Each year in the past 5 years **KNSL** has been profitable.

Each year in the past 5 years **KNSL** had a positive operating cash flow.

Looking at the **Return On Assets**, with a value of **8.44%**, **KNSL** belongs to the top of the industry, outperforming **99.29%** of the companies in the same industry.

The last **Return On Invested Capital** (**8.11%**) for **KNSL** is above the 3 year average (**7.21%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 8.44% | ||

ROE | 29.51% | ||

ROIC | 8.11% |

ROA(3y)7.16%

ROA(5y)6.6%

ROE(3y)23.84%

ROE(5y)20.49%

ROIC(3y)7.21%

ROIC(5y)6.15%

In the last couple of years the **Profit Margin** of **KNSL** has grown nicely.

In the last couple of years the **Operating Margin** of **KNSL** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 31.45% | ||

PM (TTM) | 26.62% | ||

GM | N/A |

OM growth 3Y18.57%

OM growth 5Y11.39%

PM growth 3Y8.45%

PM growth 5Y10.88%

GM growth 3YN/A

GM growth 5YN/A

The number of shares outstanding for **KNSL** has been increased compared to 1 year ago.

The debt/assets ratio for **KNSL** has been reduced compared to a year ago.

With a decent **Debt to Equity ratio** value of **0.15**, **KNSL** is doing good in the industry, outperforming **77.14%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.15 | ||

Debt/FCF | 0.2 | ||

Altman-Z | N/A |

ROIC/WACC0.98

WACC8.25%

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | N/A | ||

Quick Ratio | N/A |

The **Earnings Per Share** has been growing by **47.51%** on average over the past years. This is a very strong growth

Looking at the last year, **KNSL** shows a very strong growth in **Revenue**. The Revenue has grown by **37.85%**.

EPS 1Y (TTM)50.94%

EPS 3Y58.15%

EPS 5Y47.51%

EPS Q2Q%30.21%

Revenue 1Y (TTM)37.85%

Revenue growth 3Y39.79%

Revenue growth 5Y40.32%

Sales Q2Q%30.02%

EPS Next Y23.25%

EPS Next 2Y20.23%

EPS Next 3Y19.64%

EPS Next 5Y19.14%

Revenue Next Year34.14%

Revenue Next 2Y26.41%

Revenue Next 3Y23.06%

Revenue Next 5YN/A

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

With a **Price/Earnings** ratio of **32.19**, **KNSL** can be considered very expensive at the moment.

Compared to the rest of the industry, the **Price/Earnings** ratio of **KNSL** indicates a slightly more expensive valuation: **KNSL** is more expensive than 74.29% of the companies listed in the same industry.

The average S&P500 **Price/Earnings** ratio is at **30.52**. **KNSL** is around the same levels.

Based on the **Price/Forward Earnings** ratio of **25.71**, the valuation of **KNSL** can be described as expensive.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 32.19 | ||

Fwd PE | 25.71 |

Based on the **Enterprise Value to EBITDA** ratio, **KNSL** is valued a bit more expensive than the industry average as 62.14% of the companies are valued more cheaply.

The rest of the industry has a similar **Price/Free Cash Flow** ratio as **KNSL**.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 11.81 | ||

EV/EBITDA | 24.15 |

The excellent profitability rating of **KNSL** may justify a higher PE ratio.

PEG (NY)1.38

PEG (5Y)0.68

EPS Next 2Y20.23%

EPS Next 3Y19.64%

With a yearly dividend of 0.13%, **KNSL** is not a good candidate for dividend investing.

Compared to an average industry **Dividend Yield** of **5.25**, **KNSL** is paying slightly less dividend.

With a **Dividend Yield** of **0.13**, **KNSL** pays less dividend than the S&P500 average, which is at **2.26**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.13% |

The dividend of **KNSL** is nicely growing with an annual growth rate of **14.92%**!

Dividend Growth(5Y)14.92%

Div Incr Years7

Div Non Decr Years7

The dividend of **KNSL** is growing, but earnings are growing more, so the dividend growth is sustainable.

DP3.62%

EPS Next 2Y20.23%

EPS Next 3Y19.64%

**KINSALE CAPITAL GROUP INC**

NYSE:KNSL (9/13/2024, 8:25:43 PM)

After market: 464.53 0 (0%)**464.53**

**+7.32 (+1.6%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupInsurance

GICS IndustryInsurance

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap10.82B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.13% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 32.19 | ||

Fwd PE | 25.71 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)1.38

PEG (5Y)0.68

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 8.44% | ||

ROE | 29.51% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 31.45% | ||

PM (TTM) | 26.62% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.32

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.15 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | N/A | ||

Quick Ratio | N/A | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)50.94%

EPS 3Y58.15%

EPS 5Y

EPS Q2Q%

EPS Next Y23.25%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)37.85%

Revenue growth 3Y39.79%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y